computer-generated randomization schedule (SAS institute)
SAS institute is a verified supplier 
90
Structured Review
SAS institute
computer-generated randomization schedule
Computer Generated Randomization Schedule, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer-generated+randomization+schedules/computer+generated+randomization+list/pm40407865-52-19-22
Average 90 stars, based on 1 article reviews
Computer Generated Randomization Schedule, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer-generated+randomization+schedules/computer+generated+randomization+list/pm40407865-52-19-22
Average 90 stars, based on 1 article reviews
computer-generated randomization schedule - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Generated:Article Title: Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909). Article Snippet: Rationale: Saphenous vein graft disease remains a major limitation of coronary artery bypass graft surgery (CABG).. Up to 20% of vein grafts will occlude within the first year after CABG despite standard aspirin antiplatelet therapy.. However, more potent postoperative platelet inhibition with ticagrelor may improve graft patency. Article Title: Intensive versus moderate atorvastatin therapy and one-year graft patency after CABG: Rationale and design of the ACTIVE (Aggressive Cholesterol Therapy to Inhibit Vein Graft Events) randomized controlled trial (NCT01528709). Article Snippet: Rationale: Saphenous vein graft disease remains a major limitation of coronary artery bypass graft surgery (CABG).. Statin therapy inhibits the development of vein graft disease and improves outcomes after CABG.. However, it is unclear whether treatment with high-dose statins will further slow the process of vein graft disease and improve graft patency, as compared to conventional moderate doses. Article Title: Topical sirolimus solution for lingual microcystic lymphatic malformations in children and adults (TOPGUN): study protocol for a multicenter, randomized, assessor-blinded, controlled, stepped-wedge clinical trial Article Snippet: Allocation 4 a) Sequence generation and allocation concealment mechanism 5 Time of cross-over to the intervention will be randomly assigned to the patient at W0, W4, W8 or W12 6 with a 1:1:1:1 Article Title: CREDE Study: Intraoperative Crede Manoeuver Compared to Preoperative Prolapse Reduction Stress Test to Predict Postoperative de Novo Stress Urinary Incontinence (PONSUI) at the Time of Pelvic Organ Prolapse (POP) Surgery Article Snippet: Randomization: To address potential imbalances across study groups a computer-generated ( Software:Article Title: Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909). Article Snippet: Rationale: Saphenous vein graft disease remains a major limitation of coronary artery bypass graft surgery (CABG).. Up to 20% of vein grafts will occlude within the first year after CABG despite standard aspirin antiplatelet therapy.. However, more potent postoperative platelet inhibition with ticagrelor may improve graft patency. Article Title: Intensive versus moderate atorvastatin therapy and one-year graft patency after CABG: Rationale and design of the ACTIVE (Aggressive Cholesterol Therapy to Inhibit Vein Graft Events) randomized controlled trial (NCT01528709). Article Snippet: Rationale: Saphenous vein graft disease remains a major limitation of coronary artery bypass graft surgery (CABG).. Statin therapy inhibits the development of vein graft disease and improves outcomes after CABG.. However, it is unclear whether treatment with high-dose statins will further slow the process of vein graft disease and improve graft patency, as compared to conventional moderate doses. Article Title: Topical sirolimus solution for lingual microcystic lymphatic malformations in children and adults (TOPGUN): study protocol for a multicenter, randomized, assessor-blinded, controlled, stepped-wedge clinical trial Article Snippet: Allocation 4 a) Sequence generation and allocation concealment mechanism 5 Time of cross-over to the intervention will be randomly assigned to the patient at W0, W4, W8 or W12 6 with a 1:1:1:1 Article Title: CREDE Study: Intraoperative Crede Manoeuver Compared to Preoperative Prolapse Reduction Stress Test to Predict Postoperative de Novo Stress Urinary Incontinence (PONSUI) at the Time of Pelvic Organ Prolapse (POP) Surgery Article Snippet: Randomization: To address potential imbalances across study groups a computer-generated ( |